Cargando…

Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint

BACKGROUND: The Anglia Menorrhagia Education Study (AMES) is a randomized controlled trial testing the effectiveness of an education package applied to general practices. Binary data are available from two sources; general practitioner reported referrals to hospital, and referrals to hospital determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Richard M, Duffy, Stephen W, Fender, Guy RK
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270060/
https://www.ncbi.nlm.nih.gov/pubmed/14507420
http://dx.doi.org/10.1186/1471-2288-3-17
_version_ 1782121021548003328
author Nixon, Richard M
Duffy, Stephen W
Fender, Guy RK
author_facet Nixon, Richard M
Duffy, Stephen W
Fender, Guy RK
author_sort Nixon, Richard M
collection PubMed
description BACKGROUND: The Anglia Menorrhagia Education Study (AMES) is a randomized controlled trial testing the effectiveness of an education package applied to general practices. Binary data are available from two sources; general practitioner reported referrals to hospital, and referrals to hospital determined by independent audit of the general practices. The former may be regarded as a surrogate for the latter, which is regarded as the true endpoint. Data are only available for the true end point on a sub set of the practices, but there are surrogate data for almost all of the audited practices and for most of the remaining practices. METHODS: The aim of this paper was to estimate the treatment effect using data from every practice in the study. Where the true endpoint was not available, it was estimated by three approaches, a regression method, multiple imputation and a full likelihood model. RESULTS: Including the surrogate data in the analysis yielded an estimate of the treatment effect which was more precise than an estimate gained from using the true end point data alone. CONCLUSIONS: The full likelihood method provides a new imputation tool at the disposal of trials with surrogate data.
format Text
id pubmed-270060
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-2700602003-11-21 Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint Nixon, Richard M Duffy, Stephen W Fender, Guy RK BMC Med Res Methodol Research Article BACKGROUND: The Anglia Menorrhagia Education Study (AMES) is a randomized controlled trial testing the effectiveness of an education package applied to general practices. Binary data are available from two sources; general practitioner reported referrals to hospital, and referrals to hospital determined by independent audit of the general practices. The former may be regarded as a surrogate for the latter, which is regarded as the true endpoint. Data are only available for the true end point on a sub set of the practices, but there are surrogate data for almost all of the audited practices and for most of the remaining practices. METHODS: The aim of this paper was to estimate the treatment effect using data from every practice in the study. Where the true endpoint was not available, it was estimated by three approaches, a regression method, multiple imputation and a full likelihood model. RESULTS: Including the surrogate data in the analysis yielded an estimate of the treatment effect which was more precise than an estimate gained from using the true end point data alone. CONCLUSIONS: The full likelihood method provides a new imputation tool at the disposal of trials with surrogate data. BioMed Central 2003-09-24 /pmc/articles/PMC270060/ /pubmed/14507420 http://dx.doi.org/10.1186/1471-2288-3-17 Text en Copyright © 2003 Nixon et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Nixon, Richard M
Duffy, Stephen W
Fender, Guy RK
Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
title Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
title_full Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
title_fullStr Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
title_full_unstemmed Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
title_short Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
title_sort imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270060/
https://www.ncbi.nlm.nih.gov/pubmed/14507420
http://dx.doi.org/10.1186/1471-2288-3-17
work_keys_str_mv AT nixonrichardm imputationofatrueendpointfromasurrogateapplicationtoaclusterrandomizedcontrolledtrialwithpartialinformationonthetrueendpoint
AT duffystephenw imputationofatrueendpointfromasurrogateapplicationtoaclusterrandomizedcontrolledtrialwithpartialinformationonthetrueendpoint
AT fenderguyrk imputationofatrueendpointfromasurrogateapplicationtoaclusterrandomizedcontrolledtrialwithpartialinformationonthetrueendpoint